Technical Analysis for GSK - Glaxosmithkline Plc

Grade Last Price % Change Price Change
B 1416.0 0.45% 6.40
GSK closed up 0.45 percent on Friday, July 23, 2021, on 48 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Jul 28
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Flat
Historical GSK trend table...

Date Alert Name Type % Chg
Cup with Handle Other 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.45%
Cup with Handle Other 0.45%
Bollinger Band Squeeze Range Contraction 0.45%
NR7 Range Contraction 0.45%
BB Squeeze + Lower Band Touch Range Contraction 0.45%
Lower Bollinger Band Touch Weakness 0.45%
Older End-of-Day Signals for GSK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Glaxosmithkline Plc Description

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines, vaccines and consumer healthcare products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. The Consumer Healthcare business develops and markets products in Wellness, Oral health, Nutrition and Skin health categories. Its product portfolio includes Adartrel, Bexsero, Daraprim and Quinvaxem. Its brands include Panadol, abreva, polident and physiogel.


Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Health Consumer Healthcare Pharmaceutical Biotechnology Medicine Pharmaceuticals Disease Diseases Oncology Skin Smith Nutrition Hiv Pharmaceutical Industry Respirator Pharmacy Axe Infectious Disease Infectious Respiratory Disease Vaccine Infectious Diseases Pharmacology Respiratory Diseases Inflammation Consumer Healthcare Glaxosmithkline Healthcare Products Glaxosmithkline Pharmaceuticals Ltd

Is GSK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 1631.6
52 Week Low 1190.8
Average Volume 6,588,541
200-Day Moving Average 1355.02
50-Day Moving Average 1397.97
20-Day Moving Average 1426.25
10-Day Moving Average 1421.82
Average True Range 20.01
ADX 27.81
+DI 19.84
-DI 13.93
Chandelier Exit (Long, 3 ATRs) 1389.03
Chandelier Exit (Short, 3 ATRs) 1461.24
Upper Bollinger Bands 1448.64
Lower Bollinger Band 1403.86
Percent B (%b) 0.27
BandWidth 3.14
MACD Line 3.71
MACD Signal Line 8.35
MACD Histogram -4.6383
Fundamentals Value
Market Cap 71.05 Billion
Num Shares 5.02 Billion
EPS 126.30
Price-to-Earnings (P/E) Ratio 11.21
Price-to-Sales 2.05
Price-to-Book 4.88
PEG Ratio 11.13
Dividend 0.76
Dividend Yield 0.05%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1435.50
Resistance 3 (R3) 1434.40 1426.80 1432.25
Resistance 2 (R2) 1426.80 1421.83 1427.35 1431.17
Resistance 1 (R1) 1421.40 1418.77 1424.10 1422.50 1430.08
Pivot Point 1413.80 1413.80 1415.15 1414.35 1413.80
Support 1 (S1) 1408.40 1408.83 1411.10 1409.50 1401.92
Support 2 (S2) 1400.80 1405.77 1401.35 1400.83
Support 3 (S3) 1395.40 1400.80 1399.75
Support 4 (S4) 1396.50